RLMD Market Cap & Key Metrics
Relmada Therapeutics, Inc.
$3.20
-$0.04(-1.23%)
41
Overall
60
Value
45
Tech
18
Quality
Market Cap
$345.61M
Volume
908.69K
52W Range
$1.80 - $8.00
Target Price
$10.75
RLMD market cap is $345.61M. This page lists Relmada Therapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
RLMD Key Metrics
- Market cap
- $345.61M
- EPS estimate, current year
- $-0.62
- EPS growth, 3-year
- +35.08%
- Value score
- 60
- Quality score
- 18
- Technical score
- 45
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| EBITDA | -$57.39M | -$79.98M | -$98.79M | -$161.25M | -$125.70M |
| EPS | $-1.45 | $-2.65 | $-3.28 | $-5.30 | $-7.16 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RLMD | $3.20 | -1.2% | 908.69K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Relmada Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW